EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase

Pieter A Roelofs, Mieke A M Timmermans, Bojana Stefanovska, Myrthe A den Boestert iD, Amber W M van den Borne, Hayri E Balcioglu iD, Anita M Trapman, Reuben S Harris iD, John W M Martens iD, Paul N Span iD

Cells · 18.04.2023 · 12 (8) · 1185

DOI: 10.3390/cells12081185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 18.04.2023. Verfasst von Pieter A Roelofs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Howard Hughes Medical Institute, KWF Dutch Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

APOBEC3B (A3B) is aberrantly overexpressed in a subset of breast cancers, where it associates with advanced disease, poor prognosis, and treatment resistance, yet the causes of A3B dysregulation in breast cancer remain unclear. Here, A3B mRNA and protein expression levels were quantified in different cell lines and breast tumors and related to cell cycle markers using RT-qPCR and multiplex immunofluorescence imaging. The inducibility of A3B expression during the cell cycle was additionally addressed after cell cycle synchronization with multiple methods. First, we found that A3B protein levels within cell lines and tumors are heterogeneous and associate strongly with the proliferation marker Cyclin B1 characteristic of the G2/M phase of the cell cycle. Second, in multiple breast cancer cell lines with high A3B, expression levels were observed to oscillate throughout the cell cycle and again associate with Cyclin B1. Third, induction of A3B expression is potently repressed throughout G0/early G1, likely by RB/E2F pathway effector proteins. Fourth, in cells with low A3B, induction of A3B through the PKC/ncNF-κB pathway occurs predominantly in actively proliferating cells and is largely absent in cells arrested in G0. Altogether, these results support a model in which dysregulated A3B overexpression in breast cancer is the cumulative result of proliferation-associated relief from repression with concomitant pathway activation during the G2/M phase of the cell cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleCyclin B1Cell DivisionCell CycleMCF-7 CellsCytidine DeaminaseMinor Histocompatibility Antigens

Stichwörter der Autor:innen

APOBEC3BG2/MPKC/ncNF-κB pathwayRB/E2F pathwaycell cycletranscription

Substanzen

Cyclin B1APOBEC3B protein, humanCytidine DeaminaseMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, and Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

ORCID-Profile: Myrthe A den Boestert, Hayri E Balcioglu, Reuben S Harris, John W M Martens, Paul N Span

Förderung

  • NCI NIH HHS
  • Howard Hughes Medical Institute
  • KWF Dutch Cancer Society
  • National Cancer Institute

Zitieren

APA

Roelofs, P. A., Timmermans, M. A. M., Stefanovska, B., den Boestert, M. A., van den Borne, A. W. M., Balcioglu, H. E., Trapman, A. M., Harris, R. S., Martens, J. W. M., & Span, P. N. (2023). Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase. Cells, 12(8), 1185. https://doi.org/10.3390/cells12081185

Vancouver

Roelofs PA, Timmermans MAM, Stefanovska B, den Boestert MA, van den Borne AWM, Balcioglu HE, et al. Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase. Cells. 2023;12(8):1185. doi:10.3390/cells12081185

BibTeX
@article{Roelofs2023,
  author = {Roelofs, Pieter A and Timmermans, Mieke A M and Stefanovska, Bojana and den Boestert, Myrthe A and van den Borne, Amber W M and Balcioglu, Hayri E and Trapman, Anita M and Harris, Reuben S and Martens, John W M and Span, Paul N},
  title = {Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {8},
  pages = {1185},
  doi = {10.3390/cells12081185}
}
Kostenlos starten →